Entering text into the input field will update the search result below

PhaseBio closes $49.5M capital raise

  • PhaseBio Pharmaceuticals (NASDAQ:PHAS) has closed its public offering of ~4.1M common shares at $12 per share yielding gross proceeds of $49.5M.
  • Shares are down 2% after hours.

Recommended For You

About PHASQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PHASQ--
PhaseBio Pharmaceuticals, Inc.